Fisher & Paykel’s Long-Term Trajectory Is Intact
Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...
Hosted on MSN3d
6 Doctor-Approved Ways to Protect Your Health From Wildfire Smoke and Poor Air Quality
Even if you don't live in an area where wildfires are typical, it's important to know how to protect your health.
The Lancet4d
Chronic obstructive pulmonary disease: new therapies and old needs
Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...
Hosted on MSN4d
FDA approves 1st new class of opioid-free painkillers in over 20 years
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
COPD And Asthma Devices Market Is Likely To Expand USD 6.3 Billion At 12.6% CAGR By 2031
COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...